Raphael Pharmaceutical Inc. SEC filings RAPH
Raphael Pharmaceutical Inc. has 179 filings in SEC EDGAR's recent list, going back to Oct 24, 2007. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 1, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Sep 26, 2024 | — |
| CORRESP | Letter to the SEC | Sep 24, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 23, 2024 | — |
| EFFECT | Filing | Jun 13, 2023 | — |
| EFFECT | Filing | Jun 13, 2023 | — |
| EFFECT | Filing | Jul 8, 2022 | — |
| CORRESP | Letter to the SEC | Jul 6, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 30, 2022 | — |
| EFFECT | Filing | May 27, 2022 | — |
| EFFECT | Filing | Dec 1, 2021 | — |
| CORRESP | Letter to the SEC | Nov 29, 2021 | — |
| CORRESP | Letter to the SEC | Nov 24, 2021 | — |
| UPLOAD | Letter from the SEC | Nov 18, 2021 | — |
| NT 10-Q | Notification of late filing | Nov 15, 2021 | Sep 30, 2021 |
| UPLOAD | Letter from the SEC | Sep 27, 2021 | — |
| CORRESP | Letter to the SEC | Sep 23, 2021 | — |
| 10-12G/A | Amendment no. 2 to form 10-12g | Sep 23, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 20, 2021 | — |
| CORRESP | Letter to the SEC | Sep 2, 2021 | — |
| 10-12G/A | Amendment no. 1 to form 10-12g/a | Sep 2, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 31, 2021 | — |
| 10-12G | General form for registration of securities | Jul 29, 2021 | — |
| RW | Form rw | Jul 13, 2021 | — |
| 10-12G/A | Amendment no. 1 form 10-12g | Jul 2, 2021 | — |
| 10-12G | General form for registration of securities | May 14, 2021 | — |
| REVOKED | Filing | Feb 20, 2014 | — |
| NT 10-K | 12b-25 of easy energy, inc. | Apr 1, 2010 | Dec 31, 2009 |
| NT 10-Q | 12b-25 of easy energy, inc. | Nov 16, 2009 | Sep 30, 2009 |
| POS EX | Post-effective amendment 1 to form s-1 | Nov 16, 2009 | — |
| UPLOAD | Letter from the SEC | Sep 15, 2009 | — |
| UPLOAD | Letter from the SEC | Sep 1, 2009 | — |
| CORRESP | Letter to the SEC | Aug 26, 2009 | — |
| UPLOAD | Letter from the SEC | Aug 13, 2009 | — |
| NT 10-Q | 12b-25 of easy energy, inc. | Nov 14, 2008 | Sep 30, 2008 |
| EFFECT | Filing | Oct 31, 2008 | — |
| CORRESP | Letter to the SEC | Oct 29, 2008 | — |
| CORRESP | Letter to the SEC | Oct 23, 2008 | — |
| UPLOAD | Letter from the SEC | Sep 30, 2008 | — |
| UPLOAD | Letter from the SEC | Aug 27, 2008 | — |
| NT 10-Q | 12b-25 of easy energy, inc. | Aug 14, 2008 | Jun 30, 2008 |
| UPLOAD | Letter from the SEC | Jul 25, 2008 | — |
| UPLOAD | Letter from the SEC | May 22, 2008 | — |
| REGDEX | Auto-generated paper document | Mar 25, 2008 | — |
| 10KSB/A | Amendment no. 1 to form 10-ksb | Mar 21, 2008 | Dec 31, 2007 |
| 10KSB | Annual report for the year ended 12-31-07 | Mar 11, 2008 | Dec 31, 2007 |
| 8-A12G | Form 8-a of easy energy, inc. | Jan 4, 2008 | — |
| EFFECT | Filing | Dec 17, 2007 | — |
| CORRESP | Letter to the SEC | Dec 14, 2007 | — |
| CORRESP | Letter to the SEC | Dec 11, 2007 | — |
| UPLOAD | Letter from the SEC | Dec 6, 2007 | — |
| SB-2/A | Amendment no. 2 to form sb-2 | Dec 6, 2007 | — |
| SB-2/A | Amendment no. 1 to form sb-2 | Nov 21, 2007 | — |
| UPLOAD | Letter from the SEC | Nov 15, 2007 | — |
| SB-2 | Filing | Oct 24, 2007 | — |
Showing 54 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- RAPH (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Las Vegas, NV
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1415397
- Former names
- Easy Energy Inc (until May 14, 2021)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.